Schedule 13D ownership disclosure

RVL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: G6S41R101

Event date: 2022-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,032,995
Percent of class
1.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-088032
Form type
SC 13D/A
Filer
Avista Capital Partners III GP, L.P.
CIK
CIK 1705722
Filed
Aug 09, 2022
Reporting period
Aug 08, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub